Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Holdco Nuvo Group D.G Ltd. Ordinary Shares (NUVO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/24/2024: NUVO (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Above Average Performance
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Analysis of Past Performance
Type Stock | Historic Profit 5.02% | Avg. Invested days 142 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 10/24/2024 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 5.65M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 5641 | Beta -0.41 | 52 Weeks Range 0.00 - 21.50 | Updated Date 04/1/2025 |
52 Weeks Range 0.00 - 21.50 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.01 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Revenue by Geography
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -17524.49% |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 11052935 | Price to Sales(TTM) 0.17 |
Enterprise Value 11052935 | Price to Sales(TTM) 0.17 | ||
Enterprise Value to Revenue 62.8 | Enterprise Value to EBITDA - | Shares Outstanding 33261500 | Shares Floating 9927622 |
Shares Outstanding 33261500 | Shares Floating 9927622 | ||
Percent Insiders 39.62 | Percent Institutions 1.44 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Holdco Nuvo Group D.G Ltd. Ordinary Shares
Company Overview
History and Background
Holdco Nuvo Group D.G Ltd. Ordinary Shares (ticker NVRO) focuses on perinatal health solutions. Founded in Israel, Nuvo developed INVU by Nuvou2122, a remote pregnancy monitoring platform. The company is dedicated to improving maternal and fetal health outcomes by offering advanced technology and innovative care solutions.
Core Business Areas
- Remote Pregnancy Monitoring: INVU by Nuvou2122 is the primary product, offering continuous fetal and maternal heart rate monitoring remotely.
Leadership and Structure
Kelly Londy is the Chief Executive Officer. The company has a board of directors overseeing strategic decisions.
Top Products and Market Share
Key Offerings
- INVU by Nuvou2122: INVU is a remote pregnancy monitoring system designed to provide continuous data on fetal and maternal heart rates. The market share is still developing, as it's a relatively new entrant. Competitors include traditional fetal monitoring devices and emerging telehealth solutions. They have minimal to no market share.
Market Dynamics
Industry Overview
The perinatal health market is growing, driven by increasing awareness of maternal and fetal health. Telehealth solutions are gaining traction due to their convenience and accessibility.
Positioning
Nuvo is positioned as an innovator in remote pregnancy monitoring, focusing on providing convenient and comprehensive data for both patients and healthcare providers.
Total Addressable Market (TAM)
The global maternal and infant care market is projected to reach hundreds of millions of dollars. Nuvo is positioned to capture a portion of this market with its innovative remote monitoring technology.
Upturn SWOT Analysis
Strengths
- Innovative remote monitoring technology
- Focus on maternal and fetal health
- Potential for improved patient outcomes
Weaknesses
- Limited market share
- Reliance on single product
- Financial performance requires improvement
Opportunities
- Expanding telehealth market
- Partnerships with healthcare providers
- Increasing awareness of maternal and fetal health
Threats
- Competition from established medical device companies
- Regulatory hurdles
- Technological advancements by competitors
Competitors and Market Share
Key Competitors
- GEHC
- PHG
- Medtronic
Competitive Landscape
Nuvo faces stiff competition from established medical device companies with greater resources and market presence.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Limited historical revenue generation due to the product's recent launch.
Future Projections: Future growth depends on the adoption rate of INVU by Nuvou2122 and the company's ability to secure funding.
Recent Initiatives: Focusing on commercializing INVU by Nuvou2122 and expanding its market reach.
Summary
Nuvo Group operates in the perinatal health sector with its innovative INVU remote monitoring device. The company's potential lies in the growing telehealth market, but its financial performance presents significant challenges. It needs to secure funding and increase market penetration to compete effectively with established players. The future success hinges on market adoption and strategic partnerships.
Similar Companies
GEHC
GE HealthCare Technologies Inc.
GEHC
GE HealthCare Technologies Inc.
MDT
Medtronic PLC
MDT
Medtronic PLC
PHG
Koninklijke Philips NV ADR
PHG
Koninklijke Philips NV ADR
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Press Releases
- Market Reports
Disclaimers:
This analysis is based on available information and is not financial advice. Investment decisions should be made based on individual risk tolerance and due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Holdco Nuvo Group D.G Ltd. Ordinary Shares
Exchange NYSE MKT | Headquaters - | ||
IPO Launch date 2024-05-01 | CEO & Director Mr. Robert Maurice Powell Jr. | ||
Sector Healthcare | Industry Medical Devices | Full time employees - | Website https://www.nuvocares.com |
Full time employees - | Website https://www.nuvocares.com | ||
Holdco Nuvo Group D.G Ltd engages in the research, development, and marketing of medical devices for pregnancy monitoring in Israel, the United States, and internationally. It provides INVU platform, a remote pregnancy monitoring platform that provides expectant mothers with a self -administered wireless sensory band, which enables them and their obstetricians to monitor maternal and fetal heart rate, and maternal uterine activity at home and in the clinic from the 32nd week of pregnancy until the beginning of labor. The company's INVU platform includes a wireless sensory band with multi-modality technology to capture signals to enable the INVU platform; and a cloud computing environment that processes and analyzes data and transmits personalized reports on maternal and fetal health metrics to the expectant mother and her obstetrician through digital visualization tools. It has a collaboration with Royal Philips and Charité " Universitätsmedizin Berlin. The company was formerly known as Nuvo Group Ltd. and changed its name to Holdco Nuvo Group D.G Ltd in May 2024. Holdco Nuvo Group D.G Ltd incorporated in 2006 and is headquartered in Tel Aviv, Israel. On August 22, 2024, Holdco Nuvo Group D.G Ltd filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.